# contextual query Astrocyte-like TAMs

Query: The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Myeloid.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['LRMDA', 'DOCK8', 'TBXAS1', 'CD74', 'ARHGAP15', 'APBB1IP', 'C3', 'LNCAROD', 'ADAM28', 'FYB1']

The gene list you provided—**LRMDA, DOCK8, TBXAS1, CD74, ARHGAP15, APBB1IP, C3, LNCAROD, ADAM28, FYB1**—is enriched in myeloid cells within the glioblastoma tumor microenvironment. Analyzing these genes sheds light on the **state, properties, and interactions of these myeloid cells**, both in the context of glioblastoma and in normal physiology.

### Key Cell States and Functional Properties

**Immunosuppression and Antigen Presentation:**
- **CD74** is a well-known MHC class II chaperone and receptor for the cytokine MIF (macrophage migration inhibitory factor), suggesting a role in **antigen processing/presentation** as well as potential involvement in transmitting survival signals within myeloid cells. In tumors, CD74 expression in myeloid cells is often linked to *immune modulation* and can contribute to tumor-associated immunosuppression.
- **C3** encodes complement component 3, central to both innate immunity and immune cell recruitment. In the tumor microenvironment, C3 can promote chronic inflammation, recruit immunosuppressive myeloid cells, and contribute to tumor progression[3]. In normal settings, C3 is critical for opsonization and clearance of pathogens or debris.

**Cell Migration, Adhesion, and Cytoskeletal Dynamics:**
- **DOCK8** and **APBB1IP (RIAM)** regulate cytoskeletal rearrangements essential for **cell migration**, immune synapse formation, and interactions with other immune cells. DOCK8, in particular, is required for dendritic cell migration and T cell interactions.
- **ARHGAP15** is a GTPase-activating protein with roles in modulating cytoskeletal dynamics, which can affect the trafficking and functional polarization of myeloid cells.
- **FYB1 (ADAP)** and **APBB1IP** are adaptors involved in **integrin signaling** and immune cell adhesion, important for recruitment to inflamed or tumorous tissue and participation in immune synapse formation.

**Metabolic and Developmental Adaptation:**
- **TBXAS1** encodes thromboxane synthase, involved in eicosanoid biosynthesis, pointing to a **shift toward lipid-based signaling** in inflammatory and hypoxic microenvironments such as glioblastoma[4]. Thromboxanes can modulate vascular tone, platelet aggregation, and potentially paracrine signaling in the TME.
- The glioblastoma microenvironment is highly hypoxic and nutrient-depleted, which means immune and myeloid cells often adapt by shifting metabolism (e.g., increased glycolysis or alternative fuel use)[4]. The presence of TBXAS1 and lipid metabolism genes indicates engagement with these metabolic adaptations.

**Differentiation and Cell Fate:**
- **LRMDA** (melanocyte differentiation associated gene) is less characterized but may reflect developmental pathways shared among tissue-resident macrophages or specialized myeloid subsets.

**Protease Activity and Extracellular Matrix (ECM) Remodeling:**
- **ADAM28** is a metalloproteinase involved in **ECM remodeling** and can facilitate myeloid cell migration through tissue, modulate cell-cell interactions, and potentially promote tumor invasion by altering physical barriers.

**Non-coding RNA and Regulatory Networks:**
- **LNCAROD** is a long non-coding RNA that may play a regulatory role in cell fate, immune signaling, or metabolic adaptation, though its specific role in myeloid cells is less well defined.

### Properties and Interactions

**Functional Features Likely Inferred:**
- These myeloid cells are **activated and metabolically adapted** to the hypoxic, nutrient-poor tumor microenvironment[4].
- They are likely participating in **immune suppression** (via CD74, C3, and metabolic shifts), **promotion of tumor growth** (via ECM remodeling, antigen presentation, and chronic inflammation), and **cross-talk with both tumor and stromal cells**.
- The **enrichment of migration/adhesion-related genes** suggests dynamic movement and interaction, facilitating their recruitment to, and retention in, the tumor microenvironment.

### Context Beyond Cancer

- In normal tissues, these genes guide **immune surveillance, tissue repair, and resolution of inflammation**. For example, complement (C3) mediates clearance of apoptotic debris, CD74 and MHC-II regulate immune tolerance, and ECM remodeling enzymes modulate tissue architecture during repair and development.
- During development, such myeloid cells (e.g., microglia in the CNS) shape neural circuits, clear apoptotic neurons, and maintain tissue homeostasis through similar gene pathways.

### Summary Table: Main Functions

| Gene        | Principal Function(s) for Myeloid Cells                  | Context in Tumor/Normal Tissue                |
|-------------|----------------------------------------------------------|-----------------------------------------------|
| LRMDA       | Differentiation, possibly in resident macrophages        | Tissue-specific development/homeostasis       |
| DOCK8       | Migration, cytoskeleton, immune synapse                  | Antigen presentation, migration in TME        |
| TBXAS1      | Eicosanoid synthesis, inflammation                       | Metabolic adaptation, vascular modulation     |
| CD74        | Antigen presentation, immune regulation                  | Immunosuppression, inflammation               |
| ARHGAP15    | Cytoskeletal regulation, migration                       | Activation/migration in inflammation/tumors   |
| APBB1IP     | Integrin signaling, cell adhesion                        | Recruitment/migration, immune synapse         |
| C3          | Complement, inflammation, phagocytosis                   | Immune cell recruitment, chronic inflammation |
| LNCAROD     | Non-coding RNA, regulation                               | Possible immune/metabolic adaptation          |
| ADAM28      | ECM remodeling, migration                                | Facilitates infiltration, tumor invasion      |
| FYB1        | Signaling adaptor, cell adhesion                         | Recruitment, immune activation/suppression    |

Collectively, these genes mark a **myeloid cell population** that is metabolically adapted, highly interactive with the microenvironment, actively migratory, and potentially immunosuppressive—a profile consistent with tumor-associated macrophages and myeloid-derived suppressor cells in glioblastoma[1][3][4]. These same pathways are involved in normal immune surveillance, wound healing, and tissue homeostasis.



## References

- [1] IMMU-25. ANALYSIS OF IMMUNOSUPPRESSIVE MYELOID CELLS IN THE GLIOBLASTOMA TUMOR MICROENVIRONMENT REVEALS THERAPEUTICALLY TARGETABLE IMMUNOMODULATORY SIGNALS ACROSS POPULATIONS https://academic.oup.com/neuro-oncology/article/25/Supplement_5/v147/7406141 2023-11-01 None
- [2] OS07.1.A INTEGRATIVE SINGLE NUCLEI, SPATIAL, AND FUNCTIONAL GENOMIC ANALYSES REVEAL DNA-PK DRIVES GLIOBLASTOMA RADIORESISTANCE THROUGH TUMOR CELLS AND THE MYELOID MICROENVIRONMENT https://academic.oup.com/neuro-oncology/article/26/Supplement_5/v22/7825124 2024-10-01 None
- [3] Insights into the glioblastoma tumor microenvironment: current and emerging therapeutic approaches https://www.frontiersin.org/articles/10.3389/fphar.2024.1355242/full 2024-03-08 None
- [4] Metabolic adaptation of myeloid cells in the glioblastoma microenvironment https://www.frontiersin.org/articles/10.3389/fimmu.2024.1431112/full 2024-12-23 None
- [5] TMIC-20. UNLOCKING THE POTENTIAL OF HYPOXIA REDUCTION IN RESHAPING THE GLIOBLASTOMA TUMOR MICROENVIRONMENT FOR ENHANCED THERAPEUTIC SYNERGY https://academic.oup.com/neuro-oncology/article/26/Supplement_8/viii301/7890215 2024-11-01 None